ALX Oncology Holdings (ALXO) Stock Price, Quote, News & History | Benzinga

ALX Oncology Holdings Inc (ALXO) Stock Price, Quote, News & History

ALXONASDAQ

Trade with Public

Trade with Public

$2.00

0.010.5%

At close: Aug 24, 5:00 PM EST

$2.00

0.010.5%

Pre-Market: 4:09 AM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

-

Close

$2.00

Volume / Avg.

0 / 1.38M

Day Range

- - -

52 Wk Range

0.96 - 2.66

Market Cap

$269.13M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

51

Short Interest

6.38%

Days to Cover

13.28

Recent ALX Oncology Holdings Inc News

Why Palo Alto Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

This Zscaler Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday

Avi Kapoor

Top 3 Health Care Stocks Which Could Rescue Your Portfolio This Month

Avi Kapoor

Crude Oil Moves Lower; Moderna Shares Plunge

Avi Kapoor

Dow Dips Over 500 Points; ISM Manufacturing PMI Falls In July

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-70.78M

Investing Cash Flow (TTM)

-65.89M

Financing Cash Flow (TTM)

140.25M

Free Cash Flow (TTM)

-70.95M

Capital Expenditure (TTM)

-172.00K

Net Change in Cash (TTM)

3.59M

Analyst Trends and Forecast

2

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$148.03M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

2.03

Earnings Yield % (TTM)

-57.50%

Earnings Yield % (FWD)

-27.50%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.98

Company Debt

Total Debt

$9.71M

LT Debt

$9.71M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$1.36M

Total Cash

$22.69M

Debt to Equity

0.07

Issuance of Debt (TTM)

$8.64M

Repayment of Debt (TTM)

-$1.36M

Key Statistics

Open

-

Close

$2.00

Volume / Avg.

0 / 1.38M

Day Range

- - -

52 Wk Range

0.96 - 2.66

Market Cap

$269.13M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

51

Short Interest

6.38%

Days to Cover

13.28

About

Sector

Health Care

Industry

Biotechnology

ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, ...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy ALX Oncology Holdings (ALXO) stock?

A

You can purchase shares of ALX Oncology Holdings (NASDAQ:ALXO) through any online brokerage.

View our list of the best stock brokerages

Q

Who are ALX Oncology Holdings (ALXO) competitors?

A

Other companies in ALX Oncology Holdings’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for ALX Oncology Holdings (ALXO) stock?

A

ALX Oncology Holdings has a consensus price target of $5.69.

Q

What is the current price for ALX Oncology Holdings (ALXO)?

A

The stock price for ALX Oncology Holdings (NASDAQ: ALXO) is $2 last updated August 25, 2026 at 4:36 PM EDT.

Q

Does ALX Oncology Holdings (ALXO) pay a dividend?

A

There are no upcoming dividends for ALX Oncology Holdings.

Q

When is ALX Oncology Holdings (NASDAQ:ALXO) reporting earnings?

A

ALX Oncology Holdings does not have any upcoming earnings scheduled.

Q

Is ALX Oncology Holdings (ALXO) going to split?

A

There is no upcoming split for ALX Oncology Holdings.

Q

What sector and industry does ALX Oncology Holdings (ALXO) operate in?

A

ALX Oncology Holdings is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.